Troutman Pepper Counsels Pharma Nobis Investment Group in Acquisition of Fagron's Contract Manufacturing Business, Manufacturing Facility
February 08, 2022
February 08, 2022
NEW YORK, Feb. 8 -- Troutman Pepper, a law firm, issued the following news on Feb. 7, 2022:
Troutman Pepper advised an investment consortium Pharma Nobis, LLC - which includes Signet Healthcare Partners, Bionpharma, Inc, and GMS Capital Partners LLC - in its planned acquisition of Fagron's U.S. contract manufacturing business. This business unit, operating from a manufacturing facility in Texarkana, Texas, provides contract manufacturing and private label services for consumer . . .
Troutman Pepper advised an investment consortium Pharma Nobis, LLC - which includes Signet Healthcare Partners, Bionpharma, Inc, and GMS Capital Partners LLC - in its planned acquisition of Fagron's U.S. contract manufacturing business. This business unit, operating from a manufacturing facility in Texarkana, Texas, provides contract manufacturing and private label services for consumer . . .